Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
Submitted by
admin
on November 18, 2013 - 10:01am
Source:
Motley Fool
News Tags:
heart disease
Amgen
statins
Regeneron
Pfizer
Sanofi
PCSK9 inhibitors
Headline:
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
Do Not Allow Advertisers to Use My Personal information
